Brevican Antibodies

Santa Cruz Biotechnology features a diverse variety of Brevican monoclonal antibodies for investigating Brevican's role in various biological processes. Brevican monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Brevican, a key member of the aggrecan family of proteoglycans, plays a crucial role in the structure and function of the extracellular matrix in the central nervous system. Brevican actively participates in cell adhesion and migration processes throughout the central nervous system. The protein's involvement in neuronal signaling regulation makes it particularly relevant for studying neurodegenerative diseases and brain injuries. Research has shown that Brevican expression patterns change significantly during neural development and in response to various pathological conditions. Understanding Brevican's molecular mechanisms and interactions provides valuable insights into potential therapeutic approaches for neurological disorders. Investigating Brevican's distribution and activity patterns helps reveal its impact on synaptic plasticity and neural circuit formation. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance our understanding of neurological development and disease mechanisms.